Miller, Eric A.
Capone, Christy
Eaton, Erica
Swift, Robert M.
Haass-Koffler, Carolina L. https://orcid.org/0000-0002-5634-5679
Funding for this research was provided by:
NIMH (R25MH101075)
Article History
Accepted: 4 June 2025
First Online: 10 July 2025
Declarations
:
: E.A.M. is supported by NIMH R25MH101075 “Promoting Research Training During Psychiatry Residency”, PI: A. Tyrka.
: E.A.M., C.C., E.E., and R.M.S. declare no competing interests. C.L.H.-K. received mifepristone and placebo for another trial and travel support to present at the Corcept Therapeutics Scientific Conference (September 2022). She holds two patents for the development of negative allosteric modulators and one patent for the development of a compound for noradrenergic blockade; all are unrelated to this work.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: E.A.M. conceptualized and wrote the initial draft of the manuscript. E.A.M., E.E., C.C., R.M.S., and C.L.H-K. wrote the manuscript. C.L.H-K. oversaw the project as PI. All authors have read and approved the final submitted manuscript, and agree to be accountable for the work.